Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

498 Press Releases
DateTitleCompany
01 Apr 15 Catamaran Informed Trends™ Report Reveals Diabetes Drove Traditional Drug Trend; Specialty Trend Grew to 20 Percent TMX Equicom,
Published by
PR Newswire
01 Apr 15 Mirena Litigation News: 15 Cases to be selected for Eligibility for Second Trial Says Lawsuitsettlementnews.com CNJ ENTERPRISES LLC,
Published by
PR Newswire
31 Mar 15 Five of the World’s Top 20 Pharmaceutical Companies Standardize on Veeva Vault eTMF to Manage Clinical Trial Documents Globally Veeva,
Published by
PharmiWeb.com
31 Mar 15 Farrow and Jones Breathe New Life Into PM Society as Preparations Begin for 30th PM Society Awards in 2016 PM Society
31 Mar 15 PROCLINICAL NAMED AS TOP SCIENTIFIC RECRUITER ProClinical
31 Mar 15 Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares Valeant Pharmaceuticals International
31 Mar 15 CRO TO EXPAND GMP CAPABILITY Onyx Scientific,
Published by
Ramarketing
30 Mar 15 UCB secures multimillion pound funding boost from UK Government UCB
30 Mar 15 CRO TO EXPAND GMP CAPABILITY PharmiWeb.com
30 Mar 15 Type 2 diabetes: CHMP recommends empagliflozin/metformin hydrochloride for approval in the European Union Boehringer Ingelheim and Lilly
30 Mar 15 Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving Baxter,
Published by
PharmiWeb.com
30 Mar 15 Teva Reinforces Leadership Position in CNS with Acquisition of Auspex Teva,
Published by
PharmiWeb.com
30 Mar 15 FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma AMGEN,
Published by
PR Newswire
30 Mar 15 European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients CSL BEHRING,
Published by
PR Newswire
30 Mar 15 LEO Pharma A/S announces regulatory submission of ENSTILAR® for psoriasis in Europe LEO Pharma,
Published by
PharmiWeb.com
27 Mar 15 Merus Labs Appoints New Director and Provides European Update Merus Labs Inc.,
Published by
PR Newswire
26 Mar 15 ABPI and BIA welcome the MMIP’s successful campaign to get funding for exciting new manufacturing design processes project ABPI,
Published by
PharmiWeb.com
26 Mar 15 PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership in Pharmacovigilance Services PAREXEL,
Published by
PharmiWeb.com
26 Mar 15 Lyophilized Injectables Growth at Fourteen Percent as Biologicals Proliferate Greystone Research Associates
26 Mar 15 Approval of Antiviral Drug, Copegus® for Additional Indication Chugai Pharmaceutical Co., Ltd
26 Mar 15 Medical breakthroughs on the horizon with £32m boost for UK research MRC
26 Mar 15 BUPA STARTUP STAGE SPEAKERS ANNOUNCED FOR WIRED HEALTH WIRED Health 2015
26 Mar 15 ENCORE Clinical Data Published in The Lancet Suggest Treatment with Oral Maintenance Therapy Effective in Previously Treated Gaucher Disease Patients Genzyme
26 Mar 15 Colli-PeeTM by Novosanis nominated for IWT Innovation Award Novosanis
26 Mar 15 Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland Phosphagenics Limited
26 Mar 15 Cancer Research UK and Medidata Partner to Streamline Data Collection and Management for Cancer Clinical Trials Cancer Research UK
26 Mar 15 Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005 Transition Therapeutics Inc.,
Published by
PR Newswire
26 Mar 15 EISAI RECEIVES APPROVAL IN JAPAN FOR ANTICANCER AGENT LENVIMA® (LENVATINIB MESYLATE) AS TREATMENT FOR UNRESECTABLE THYROID CANCER EISAI,
Published by
PharmiWeb.com
26 Mar 15 Otsuka Granted Approval in Japan for a New Formulation of ABIILIFY – ABILIFY for Extended–release Injectable Suspension, for Intramuscular Use – Indicated for Schizophrenia Otsuka,
Published by
PharmiWeb.com
25 Mar 15 Wyatt Technology’s Calypso CG-MALS System Demonstrates Enhanced Capabilities for Characterization of Complex Protein-Protein Interactions Wyatt Technology,
Published by
The Scott Partnership
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.